Free Trial

Bio-Rad Laboratories (NYSE:BIO.B) Sets New 1-Year Low - Here's What Happened

Bio-Rad Laboratories logo with Medical background
Remove Ads

Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $225.29 and last traded at $225.29, with a volume of 120 shares changing hands. The stock had previously closed at $241.99.

Bio-Rad Laboratories Stock Performance

The company has a quick ratio of 4.85, a current ratio of 6.48 and a debt-to-equity ratio of 0.18. The company has a 50-day moving average price of $279.01 and a two-hundred day moving average price of $316.47. The company has a market capitalization of $6.31 billion, a PE ratio of -3.46 and a beta of 0.94.

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.90 EPS for the quarter. Bio-Rad Laboratories had a negative net margin of 71.86% and a positive return on equity of 3.90%.

Bio-Rad Laboratories Company Profile

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Featured Stories

Should You Invest $1,000 in Bio-Rad Laboratories Right Now?

Before you consider Bio-Rad Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.

While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads